PERITONEAL CARCINOMA METASTATIC

This adverse event was reported 63 times

These drugs are most commonly taken by patients reporting PERITONEAL CARCINOMA METASTATIC:

# Drug Count
0 RITUXIMAB 9
1 METHOTREXATE SODIUM 8
2 BEVACIZUMAB 7
3 ENOXAPARIN SODIUM 7
4 METHOTREXATE 7
5 ONDANSETRON 7
6 ONDANSETRON HYDROCHLORIDE 7
7 ALLOPURINOL 6
8 CARBOPLATIN 6
9 CELECOXIB 6
See all common drugs associated with PERITONEAL CARCINOMA METASTATIC

PERITONEAL CARCINOMA METASTATIC is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 NOGAPENDEKIN ALFA INBAKICEPT-PMLN 1 0.0204
1 FILGRASTIM-AAFI 1 0.0015
2 MIRVETUXIMAB SORAVTANSINE 1 0.0006
3 POLATUZUMAB VEDOTIN 5 0.0005
4 DALTEPARIN SODIUM 5 0.0005
5 DICYCLOMINE HYDROCHLORIDE 5 0.0003
6 TOBRAMYCIN AND DEXAMETHASONE 1 0.0003
7 NYSTATIN OINTMENT 5 0.0002
8 NYSTATIN CREAM 5 0.0002
9 NYSTATIN 5 0.0002
See all drugs enriched for association with PERITONEAL CARCINOMA METASTATIC

PERITONEAL CARCINOMA METASTATIC is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Cardiac Myosin Inhibitor [EPC] 1 0.0002
1 Somatostatin Analog [EPC] 1 0.0001
2 Polyene Antifungal [EPC] 5 0.0001
3 Cannabinoid [EPC] 1 0.0001
4 BCL-2 Inhibitor [EPC] 5 0.0001
5 Provitamin D2 Compound [EPC] 2 0.0001
6 Nonergot Dopamine Agonist [EPC] 1 0.0001
7 Influenza A M2 Protein Inhibitor [EPC] 1 0.0001
8 Serotonin-3 Receptor Antagonist [EPC] 7 0.0001
9 Antirheumatic Agent [EPC] 5 0.0000
See all drug classes enriched for association with PERITONEAL CARCINOMA METASTATIC